Vascular Closure Device Vcd Market Size, Share - Growth Analysis Report and Forecast Trends 2026-2030

Vascular Closure Devices are specialized medical instruments designed to achieve hemostasis after arterial access procedures, eliminating the need for prolonged manual compression. The market encompasses various device types including passive closure systems, active closure mechanisms, and hybrid approaches, each suited to different access sites and patient anatomies. Valued at $1.705 billion in 2025, the market reflects robust demand stemming from the increasing volume of catheter-based interventions performed globally.

• •Primarily used post-catheterization to seal femoral and radial artery access points
• •Reduces patient recovery time and hospital stay compared to manual compression
• •Growing procedural volumes across interventional cardiology, radiology, and vascular surgery

The global burden of cardiovascular diseases, including coronary artery disease, peripheral artery disease, and aneurysms, continues to rise, driving demand for diagnostic and interventional procedures that require arterial access. An aging population with higher incidence of vascular conditions, combined with lifestyle-related risk factors, sustains procedural growth across both developed and emerging healthcare markets. Additionally, the shift toward outpatient and same-day discharge procedures has amplified adoption of VCDs that enable faster hemostasis and earlier patient mobilization.

• •Increasing prevalence of peripheral artery disease and coronary artery disease globally
• •Advantages in reducing time-to-hemostasis, bleeding complications, and patient discomfort
• •Growing preference for minimally invasive procedures over open surgical alternatives

The VCD market is segmented by device type, including passive closure (collagen-, thrombin-, and fibrin sealant-based), active mechanical closure, and hybrid systems combining both approaches. Access site-based segmentation distinguishes femoral closure devices, which dominated historically, from radial closure devices that are gaining share due to lower complication rates. North America currently leads the market due to high procedural volumes, advanced healthcare infrastructure, and early adoption of innovative technologies, while Europe and the Asia-Pacific region represent significant and accelerating growth markets driven by expanding access to interventional procedures.

• •North America accounts for the largest regional share, supported by high cardiac catheterization rates
• •Asia-Pacific emerging as the fastest-growing region due to increasing healthcare spending and procedure adoption
• •Radial access devices growing faster than femoral devices due to improved safety profiles

What are the recent trends and outlook?

The VCD market is expected to maintain steady growth trajectory through 2030, supported by continued expansion of catheter-based interventions, increasing procedural complexity, and growing adoption in radial access procedures. Innovation is steering the market toward more biocompatible materials, simplified deployment mechanisms, and devices compatible with smaller-bore access sheaths. The ongoing shift toward ambulatory surgical centers and office-based interventions, particularly in the United States, presents new adoption opportunities, while emerging markets in Asia-Pacific and Latin America are projected to accelerate as healthcare infrastructure and interventional capabilities improve.

• •Expected to reach approximately $2.4 billion by 2030 at the current 5.915% CAGR
• •Radial artery access gaining prominence due to lower complication rates and faster recovery
• •Rising adoption in emerging markets as interventional cardiology services expand